CLINICAL_TRIALS
trial_result
· 2026-01-30
Clinical Trial Update: A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors [Phase 1, Phase 2]
Summary
A first-in-human trial of GEN1078 in participants with solid tumors spanning Phase 1/2 has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genmab | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED